Significant Hemoptysis Following Left Atrial Appendage Occlusion in a Patient with Atrial Fibrillation and Thrombus: A Case Study
By
Qiqi Jin
Jianjian Yang
Shufang Wu
Shanjiang Chen
January 5, 2026
Clinical Scorecard: Significant Hemoptysis Following Left Atrial Appendage Occlusion in a Patient with Atrial Fibrillation and Thrombus: A Case Study
At a Glance
Category Detail
Condition Atrial Fibrillation with Left Atrial Appendage Thrombus Key Mechanisms Left Atrial Appendage Occlusion (LAAO) for thromboembolism prevention Target Population Patients with atrial fibrillation and thrombus in the left atrial appendage Care Setting Cardiac Care Unit and General Ward
Key Highlights
LAAO is a viable alternative for patients with persistent LAAT despite anticoagulation. Massive hemoptysis can occur post-LAAO, requiring immediate intervention. Intracardiac echocardiography (ICE) is crucial for guiding LAAO procedures. Guideline-Based Recommendations
Diagnosis
Use CHA2DS2-VASc and HAS-BLED scores to assess thromboembolism and bleeding risks. Management
Consider LAAO for patients with refractory LAAT despite anticoagulation. Monitoring & Follow-up
Close hemodynamic and respiratory monitoring post-procedure. Risks
Monitor for complications such as hemoptysis and uncontrolled hemorrhage. Patient & Prescribing Data
Elderly patients with atrial fibrillation and thrombus.
Transition from rivaroxaban to clopidogrel post-hemoptysis management.
Clinical Best Practices
Utilize ICE for accurate LAA measurement during LAAO. Implement emergency interventions for massive hemoptysis, including bronchial artery embolization. References
